Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

LifeStance Health (LFST) Accumulated Depreciation & Amortization (2020 - 2025)

Historic Accumulated Depreciation & Amortization for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $10.3 million.

  • LifeStance Health's Accumulated Depreciation & Amortization fell 62.45% to $10.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.3 million, marking a year-over-year decrease of 62.45%. This contributed to the annual value of $40.7 million for FY2024, which is 884.35% up from last year.
  • Latest data reveals that LifeStance Health reported Accumulated Depreciation & Amortization of $10.3 million as of Q3 2025, which was down 62.45% from $10.6 million recorded in Q2 2025.
  • LifeStance Health's Accumulated Depreciation & Amortization's 5-year high stood at $40.7 million during Q4 2024, with a 5-year trough of $2.6 million in Q1 2021.
  • Moreover, its 5-year median value for Accumulated Depreciation & Amortization was $10.0 million (2024), whereas its average is $12.7 million.
  • In the last 5 years, LifeStance Health's Accumulated Depreciation & Amortization surged by 30235.91% in 2021 and then crashed by 62.45% in 2025.
  • LifeStance Health's Accumulated Depreciation & Amortization (Quarter) stood at $15.1 million in 2021, then surged by 91.59% to $28.9 million in 2022, then increased by 29.23% to $37.4 million in 2023, then increased by 8.84% to $40.7 million in 2024, then tumbled by 74.57% to $10.3 million in 2025.
  • Its last three reported values are $10.3 million in Q3 2025, $10.6 million for Q2 2025, and $10.3 million during Q1 2025.